NeoLAB

Cell-free NGS analysis for solid tumor cancers

NeoLab® Solid Tumor Liquid Biopsy is an NGS assay for pan-cancer that gives you a comprehensive, single order testing solution for solid tumors. It includes 44 genes involved in solid tumor development and progression, covering actionable markers supported by clinical guidelines and on-going clinical trials.

NeoLAB® Solid Tumor Liquid Biopsy Benefits

Pan-cancer tumor types (bladder, brain/CNS, breast, cervical, colorectal, stomach, head and neck, etc.)

Detects 900+ hotspot SNVs and indels across 44 genes

Accurate results are returned within 7 calendar days after sample is received

  • 98% accuracy, 95.1% sensitivity, 98.8% specificity
  • Limit of Detection: 0.1% allele fraction for indels; 0.15% for SNV
Clinical Applications
Clinical Significance Clinical icon
Identifying targetable alterations

Identify Targetable Alteration

Check List Clinical icon
Monitoring disease status

Monitor Disease Status

Microscope & Morphologyav Clinical icon
Detecting potential resistance

Detect Potential Resistance

Genes investigated

AKT1 ERBB3 HRAS NTRK3
ALK ESR1 IDH1 PDGFRA
APC FBXW7 IDH2 PIK3CA
AR FGFR1 KIT PTEN
ARAF FGFR2 KRAS RAF1
BRAF FGFR3 MAP2K1 RET
CHEK2 FGFR4 MAP2K2 ROS1
CTNNB1 FLT3 MET SF3B1
DDR2 GNA11 MTOR SMAD4
EGFR GNAQ NRAS SMO
ERBB2 GNAS NTRK1 TP53
Test Details

See complete test details for NeoLAB® Solid Tumor Liquid Biopsy.

Get a printable test description and specimen requirements.

Learn More

Mobile Phlebotomy Program

NeoGenomics is proud to offer in-home specimen collection for liquid biopsy assays through our national mobile phlebotomy program, providing safe and convenient blood draws for liquid biopsy with no added costs for patients.

Learn More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients